Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 11/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 10/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7377258 | 0.78 | SLC6A4 (0.55) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL14962113 | 0.72 | SLC6A2 (0.77) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL14962110 | 0.72 | SLC6A2 (0.84) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL3890512 | 0.72 | SLC6A2 (0.77) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL3895159 | 0.72 | SLC6A2 (0.84) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL12064517 | 0.72 | SLC6A2 (0.84) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL635189 | 0.71 | SLC6A4 (0.78) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL635188 | 0.71 | SLC6A4 (0.78) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL635187 | 0.71 | SLC6A4 (0.78) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL3895214 | 0.70 | SLC6A2 (1.00) | SLC6A4SLC6A2SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0880502-A1 | AMINOHETEROCYCLIC DERIVATIVES AS ANTITHROMBOTIC OR ANTICOAGULANT AGENTS | ZENECA LIMITED (GB) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997028129-A1 | AMINOHETEROCYCLIC DERIVATIVES AS ANTITHROMBOTIC OR ANTICOAGULANT AGENTS | ZENECA LIMITED (GB) | 1997-08-07 | — | — | WO | disclosed |